Item 2.02. Results of Operations and Financial Condition.
On November 10, 2020, Health Catalyst, Inc. (the Company) issued a press release
relating to its financial results for the quarter ended September 30, 2020. A
copy of the press release, which is incorporated by reference herein, is
attached hereto as Exhibit 99.1.
The foregoing information (including the exhibit set forth in Item 9.01 hereto)
is being furnished and shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, except as expressly set
forth by specific reference in such filing.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 10, 2020, the Company announced that J. Patrick Nelli, the Company's
Chief Financial Officer, will step down as CFO and assume a newly-created role
of President of the Company, both effective January 1, 2021.
•Chief Financial Officer:
On November 10, 2020, the Company announced that Bryan Hunt, age 34, the
Company's Senior Vice President of Financial Planning and Analysis, will assume
the role of Chief Financial Officer of the Company, effective January 1, 2021.
Mr. Hunt has served as the Company's Senior Vice President of Financial Planning
and Analysis since 2019. Mr. Hunt has served in a variety of leadership roles in
the Company's finance function and in its internal analytics function since
joining the company in April of 2014. Prior to joining the Company, Mr. Hunt
served as an investment banker at Deloitte Corporate Finance, from 2011 to 2014.
Mr. Hunt began his career as an investment banker at Moelis & Company. Mr. Hunt
brings more than 10 years of experience in finance and operations across various
size companies to the CFO position. Mr. Hunt holds a Bachelor's degree in
Accounting from Brigham Young University, where he graduated cum laude. In
connection with his appointment, the Company expects to enter into an
indemnification agreement with Mr. Hunt and expects Mr. Hunt will participate in
its Executive Severance Plan, effective January 1, 2021.
•Chief Accounting Officer:
On November 10, 2020, the Company announced that Jason Alger, age 37, the
Company's Senior Vice President of Finance, will assume the role of Chief
Accounting Officer of the Company, effective January 1, 2021. In this role, Mr.
Alger will serve as the Company's principal accounting officer. Mr. Alger has
served as the Company's Senior Vice President of Finance since September 2017,
and as Controller since April 2013. Prior to joining the Company, Mr. Alger was
at the public accounting firm, Ernst & Young LLP, in its assurance practice from
August 2009 to April 2013. Mr. Alger is a certified public accountant and holds
a Master of Accountancy degree from Brigham Young University. In connection with
his appointment, the Company expects to enter into an indemnification agreement
with Mr. Alger and expects Mr. Alger will participate in its Executive Severance
Plan, effective January 1, 2021.
On November 9, 2020, the board of directors of the Company accepted Mike Dixon's
resignation from the board, including his resignation from the nominating and
corporate governance committee of the board, effective December 31, 2020. Mr.
Dixon's resignation is not the result of any disagreement with the Company on
any matter relating to the Company's operations, policies, or practices.
Except for the arrangements described in this Current Report on Form 8-K, there
are no existing or currently proposed transactions to which the Company or any
of its subsidiaries is a party and in which Messrs. Nelli, Hunt or Alger have a
direct or indirect material interest. There are no family relationships between
any of Messrs. Nelli, Hunt or Alger and any of the Company's directors or
A copy of the press release announcing the appointments of Messrs. Nelli, Hunt
and Alger is attached hereto as Exhibit 99.2.
Item 9.01. Financial Statements and Exhibits.
Exhibit No. Description
Health Catalyst, Inc. press release for quarterly financial
99.1* results, dated November 10, 2020Health Catalyst, Inc. press release announcing appointment of
99.2 officers, dated November 10, 2020
* Furnished herewith.
© Edgar Online, source Glimpses